Universitätsklinikum Frankfurt, Goethe Universität

Frankfurt am Main, Hesse 60590

2 studies enrolling now · 6 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chronic Myelomonocytic Leukemia, Cytopenia, Heart Failure, Hereditary Angioedema, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts

Studies at this site

• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
• A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9) — Recruiting now
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
• CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks — Completed
• Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine — Completed